Risankizumab remains effective for long-term treatment of psoriasisResults also show benefit for people with psoriasis on nails, scalp, palms or soles of feet. U.S. guidelines focus on topical therapies for vitiligo in children and young adultsGuidelines and expert consensus-based recommendations for the diagnosis and treatment of vitiligo in young patients. Case report: Bigger? Dr. Robert Dickson sees something dramatic in his walk-in that addresses common issues we don’t often consider. POP QUIZ: New treatment for alopecia areata Can you tell which statement about Litfulo (ritlecitinib), the new prescription drug for treatment of severe alopecia areata, is false? QUIZ: All about alopecia See how much you know about hair loss in its many forms! Case report: Amoxil rash? An intriguing case involving a child with a rash purportedly due to an amoxicillin allergy came to Dr. Robert Dickson’s walk-in clinic recently. Two therapeutic options now available for treating severe alopecia areata in Canada The new drug Litfulo (ritlecitinib) has reached the Canadian market, while baricitinib (Olumiant) is now approved for alopecia areata and in a new higher-strength tablet. AI helps physicians diagnose skin disease, but not for darker skin tones Physicians need more training to better diagnose dermatological conditions in skin of colour. Case report: A red itchy rash everywhere A 23-year-old woman presented at a walk-in clinic with a peculiar rash that had emerged four days after a brief period of nasal congestion. Case report: Ringworm? Working in a walk-in clinic offers a unique perspective on medical care compared to family practice—as seen with a child's persistent rash First Previous 25 26 27 28 29 Next Last
